Video


 
    Tickers News speaks to Kazia Therapeutics CEO James Garner About GBM Awareness Day  
 
    CEO James Garner presents at Gold Coast Investment Showcase  
 
    Edison TV: Kazia Therapeutics - overview and update with CEO James Garner  
 
    Kazia CEO, Dr James Garner discusses the recent positive interim data from the phase II trial of paxalisib in glioblastoma, COVID-19 and the company's recent capital raising  
 
    Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2019 Gold Coast Investment Showcase  
 
    Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the Wholesale Investor Emergence event in Brisbane  
 
    Kazia’s CEO Dr James Garner presented an overview of the company as a guest speaker at the 2018 Gold Coast Investment Showcase  
 
    Dr James Garner speaks with CommSec re our GDC-0084 Phase II trial start  
 
    NDF Research Senior Analyst Stuart Roberts interviews Kazia Therapeutics CEO Dr James Garner as the GDC-0084 phase II trial launches in the US  
 
    CommSec interview re our new name, Kazia Therapeutics and our clinical trial progress  
 
    CommSec Executive Series interviews CEO Dr James Garner on benefits of new business model for patients  
 
    Dr James Garner, CEO, speaks to Canary Networks investment forum  
 
    Sky News Interview – In-licensing of GDC-0084